This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: The J. David Gladstone Institutes. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Sarah Rosemary Carter: Innovator in Neurological Disorder Treatments
Introduction
Sarah Rosemary Carter is a prominent inventor based in Arlington, VA (US). She has made significant contributions to the field of neuroscience, particularly in the treatment of neurological disorders. Her innovative work has led to the development of methods that could potentially improve the lives of many individuals suffering from these conditions.
Latest Patents
Carter holds a patent for "Compositions and methods for treating neurological disorders." This patent outlines methods for treating neurological disorders by modulating protein kinase D1 (PKD1) activity levels in neurons or glial cells. The disclosure also includes antibodies specific for PKD1 and describes a genetically modified non-human mammal deficient in PKD1 activity. This patent represents a significant advancement in the understanding and treatment of neurological disorders, showcasing her expertise and dedication to medical innovation.
Career Highlights
Carter is affiliated with the J. David Gladstone Institutes, where she conducts her research. Her work at this esteemed institution has allowed her to collaborate with leading scientists and contribute to groundbreaking research in her field.
Collaborations
Some of her notable coworkers include Vikram Ramnath Rao and Steven M. Finkbeiner. Their collaborative efforts have further enhanced the research environment and fostered innovation in neurological studies.
Conclusion
Sarah Rosemary Carter is a trailblazer in the field of neurological disorder treatments, with her patent and research paving the way for future advancements. Her contributions are vital to the ongoing efforts to improve therapeutic strategies for those affected by neurological conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile